Managed Care Pharmacy Activities & Events

Translating KDIGO Updates and Clinical Evidence Into Managed Care Decision-Making in IgA Nephropathy

1.0 Credit / Endocrinology Diabetes and Metabolism

PBMI 2026

September 10 - September 11, 2026

An Eye on Access: Managed Care Perspectives in Demodex Blepharitis

Wednesday, September 16, 2026 | 12:00 PM & 8:00 PM EDT | Thursday, October …

Evolving Hidradenitis Suppurativa Management: Advancements in Treatment and Managed Care Integration Across Patient Populations

Tuesday, September 29, 2026 | 1:00 PM & 8:00 PM EDT | Tuesday, October 6, 2…

Improving Outcomes in Fibrosing Interstitial Lung Diseases: Exploring Novel Mechanisms of Action and New Indications to Inform Clinical and Managed Care Decision-Making

Tuesday, September 8, 2026 | 1:00 & 8:00 PM EDT

Advancing the Management of Hidradenitis Suppurativa: Emerging Therapies and Managed Care Strategies Across Patient Populations

Tuesday, September 1, 2026 | 1:00 & 8:00 PM EDT

Looking at Patient-Centered Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Through a Value-Based Lens

Friday, September 11, 2026 | 12:10 PM – 1:10 PM EDT

New Treatments in Systemic Lupus Erythematosus to Advance Care: A Managed Care Focus on Nephritis

Friday, September 11, 2026 | 7:00 AM – 8:00 AM EDT

Innovations in Narcolepsy Treatment: Emerging Targets and Implications for Managed Care

Thursday, September 10, 2026 | 12:10 PM-1:10 PM EDT

Evolving Treatment Options in Plaque Psoriasis: Implications of Emerging TYK2 Inhibitors for Managed Care

Thursday, September 10, 2026 | 7:00 AM – 8:00 AM EDT

Redefining Metabolic Dysfunction-Associated Steatohepatitis Treatment: Managed Care Insights on New Therapies Targeting Metabolic Dysfunction

1.0 Credit / Endocrinology, Diabetes and Metabolism, Gastroenterology

Improving Outcomes in Lipid Management: Aligning Managed Care Policy With Emerging Guideline Updates and Non-Statin Therapeutic Advances

1.0 Credit / Cardiology

From Evidence to Access: Integrating SGLT2 Inhibitors Across the Cardiorenal-Metabolic Continuum

1.0 Credit / Endocrinology, Diabetes & Metabolism, Nephrology

Cool Solutions: Non-Hormonal Advances in Vasomotor Symptoms Treatment

1.0 Credits / Women's Health

Improving the Identification and Management of Fibrosing Interstitial Lung Diseases Through the Power of the Multidisciplinary Care Team

1.5 Credit / Pulmonology/Respiratory

Advancing Patient-Centered Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Through Specialty Pharmacy Support

1.5 Credit / Ophthalmology/Optometry

Applying Value-Based Principles in ATTR-CM Care: Optimizing Identification, Therapy Selection, and Patient Access

1.5 Credit / Cardiology

TL1A Inhibitors in Inflammatory Bowel Disease: New Clinical Insights and Access Considerations for Managed Care and Specialty Pharmacy

1.5 Credit / Gastroenterology

From Crisis Aversion to Cost Reduction - Managed Care Insights on Enhancing Ketone Monitoring for Diabetic Ketoacidosis Prevention

3.0 Credits / Endocrinology, Diabetes & Metabolism

Optimizing Outcomes in Hereditary Angioedema: Managed Care Approaches to Diagnosis, Treatment, and Patient Quality of Life

1.5 Credit / Immunology

Optimizing Cardiorenal-Metabolic Health: A Managed Care Guide to Integrating SGLT2 Inhibitor Therapy

1.5 Credit / Endocrinology, Diabetes & Metabolism

A Managed Care Perspective on Hard-to-Control Hypertension: Understanding the Risks and Challenges in Uncontrolled and Resistant Hypertension

1.5 Credit / Cardiology

Improving Patient Outcomes in Fibrosing Interstitial Lung Diseases: Clinical and Managed Care Perspectives on the Evolving Landscape

1.5 Credit / Pulmonology/Respiratory

From Biomarkers to Better Outcomes: The Impact of Immunotherapy on the Endometrial Cancer Landscape

1.5 Credit / Women’s Health, Gynecologic Cancer, Oncology

Aligning Clinical Evidence With Managed Care Decision-Making in the Evolving Myelofibrosis Treatment Landscape

1.5 Credit / Hematologic Cancer, Hematology

Redefining Value in Transthyretin Amyloidosis Cardiomyopathy Care: Innovations in Diagnosis, Treatment, and Access

1.5 Credit / Cardiology

Next-Generation Lipid Management: Elevating Outcomes Through Managed Care Strategies

1.5 Credit / Cardiology

Evolving Therapeutic Targets in Small Cell Lung Cancer: Updates and Insights for Managed Care

1.5 Credit / Lung Cancer

New Drug Approvals for 2025 (Pharmacy Technician Credit)

2.0 Credits / General Pharmacy

New Drug Approvals for 2025 (Pharmacist Credit)

2.0 Credits / General Pharmacy

Navigating the Complexities of Personalized Prostate Cancer Care: Insights for Oncology Managed Care

2.0 Credits / Genitourinary Cancer, Men's Health, Oncology

An American Journal of Managed Care Forum: Bridging Evidence and Access in Advanced Small Cell Lung Cancer

1.5 Credit / Lung Cancer, Oncology, Pulmonology

HER2-Positive Metastatic Breast Cancer: A Managed Care Perspective on Emerging Therapies and Clinical Data

1.0 Credit / Breast Cancer, Oncology, Women's Health

Bridging Clinical and Access Gaps in Phenylketonuria: A Managed Care Perspective

1.5 Credits / Endocrinology, Diabetes & Metabolism, Rare Diseases

Addressing Gaps in Care for the Rapid and Long-Term Management of Hyperkalemia With Novel Oral Potassium Binding Agents: Insights for Managed Care Professionals

1.0 Credit / Nephrology, Cardiology

Minimizing Injection Burden: Anti-VEGF Innovation for Retinal Disease Management

1.5 Credit / Ophthalmology/Optometry

Navigating Advanced Prostate Cancer Treatment: Optimizing Novel Therapeutic Strategies for Managed Care Pharmacists

1.5 Credits / Genitourinary Cancer, Men's Health, Oncology

New Horizons in ATTR-CM: Therapeutic Advances and Strategic Insights

1.5 Credits / Cardiology, Rare Diseases

Cardiorenal Protection With SGLT2 Inhibitors: Perspectives for Managed Care

1.5 Credits / Cardiology, Endocrinology, Diabetes & Metabolism, Nephrology

Innovations in Retinal Therapies: A Managed Care Perspective on Anti-VEGF Advancements

1.0 Credit / Ophthalmology/Optometry

Bridging Innovation and Access in HR-Positive/HER2-Negative Metastatic Breast Cancer: Implications for Managed Care

1.5 Credits / Breast Cancer, Oncology

IL-23 Inhibitors in Psoriasis: Optimizing Access and Patient Outcomes Across Integrated Systems

1.0 Credits / Dermatology, Immunology

The Expanding Therapeutic Landscape in IgA Nephropathy: Translating New Clinical Evidence and Updated Guidelines Into Managed Care Strategies

1.0 Credit / Immunology, Nephrology

Optimizing Lipid Management in Statin-Intolerant Populations: Payer Strategies for Evidence-Based Access and Risk Reduction

1.0 Credits / Cardiology

The Pharmacist's Role in Palliative and End of Life Symptom Management

1.0 Credit / General Pharmacy

Paroxysmal Nocturnal Hemoglobinuria: Managed Care Strategies to Mitigate Burden and Enhance Outcomes

2.0 Credits / Immunology, Rare Diseases, Hematology

Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models

1.0 Credit / Immunology, Neurology, Rare Diseases

Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape

1.0 Credits / Dermatology, Immunology